These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 22137491

  • 1. Impact of cancer therapies on ovarian reserve.
    Gracia CR, Sammel MD, Freeman E, Prewitt M, Carlson C, Ray A, Vance A, Ginsberg JP.
    Fertil Steril; 2012 Jan; 97(1):134-40.e1. PubMed ID: 22137491
    [Abstract] [Full Text] [Related]

  • 2. Ovarian reserve after treatment with alkylating agents during childhood.
    Thomas-Teinturier C, Allodji RS, Svetlova E, Frey MA, Oberlin O, Millischer AE, Epelboin S, Decanter C, Pacquement H, Tabone MD, Sudour-Bonnange H, Baruchel A, Lahlou N, De Vathaire F.
    Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
    [Abstract] [Full Text] [Related]

  • 3. Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patients.
    Su HC, Haunschild C, Chung K, Komrokian S, Boles S, Sammel MD, DeMichele A.
    Cancer; 2014 Dec 01; 120(23):3691-8. PubMed ID: 25081546
    [Abstract] [Full Text] [Related]

  • 4. A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation.
    Jayaprakasan K, Campbell B, Hopkisson J, Johnson I, Raine-Fenning N.
    Fertil Steril; 2010 Feb 01; 93(3):855-64. PubMed ID: 19046583
    [Abstract] [Full Text] [Related]

  • 5. Impact of cancer treatment on risk of infertility and diminished ovarian reserve in women with polycystic ovary syndrome.
    Shandley LM, Fothergill A, Spencer JB, Mertens AC, Cottrell HN, Howards PP.
    Fertil Steril; 2018 Mar 01; 109(3):516-525.e1. PubMed ID: 29428311
    [Abstract] [Full Text] [Related]

  • 6. Long-term effects of childhood cancer treatment on hormonal and ultrasound markers of ovarian reserve.
    van den Berg MH, Overbeek A, Lambalk CB, Kaspers GJL, Bresters D, van den Heuvel-Eibrink MM, Kremer LC, Loonen JJ, van der Pal HJ, Ronckers CM, Tissing WJE, Versluys AB, van der Heiden-van der Loo M, Heijboer AC, Hauptmann M, Twisk JWR, Laven JSE, Beerendonk CCM, van Leeuwen FE, van Dulmen-den Broeder E, DCOG LATER-VEVO study group.
    Hum Reprod; 2018 Aug 01; 33(8):1474-1488. PubMed ID: 29982673
    [Abstract] [Full Text] [Related]

  • 7. Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer.
    Partridge AH, Ruddy KJ, Gelber S, Schapira L, Abusief M, Meyer M, Ginsburg E.
    Fertil Steril; 2010 Jul 01; 94(2):638-44. PubMed ID: 19409543
    [Abstract] [Full Text] [Related]

  • 8. Interactions between serum FSH, inhibin B and antral follicle count in the decline of serum AMH during the menstrual cycle in late reproductive age.
    Robertson DM, Lee CH, Baerwald A.
    Endocrinol Diabetes Metab; 2021 Apr 01; 4(2):e00172. PubMed ID: 33855196
    [Abstract] [Full Text] [Related]

  • 9. Antimüllerian hormone levels and antral follicle counts are not reduced compared with community controls in patients with rigorously defined unexplained infertility.
    Greenwood EA, Cedars MI, Santoro N, Eisenberg E, Kao CN, Haisenleder DJ, Diamond MP, Huddleston HG, National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development Cooperative Reproductive Medicine Network.
    Fertil Steril; 2017 Dec 01; 108(6):1070-1077. PubMed ID: 29202959
    [Abstract] [Full Text] [Related]

  • 10. Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment.
    Nyström A, Mörse H, Nordlöf H, Wiebe K, Artman M, Øra I, Giwercman A, Henic E, Elfving M.
    Acta Oncol; 2019 Feb 01; 58(2):218-224. PubMed ID: 30558460
    [Abstract] [Full Text] [Related]

  • 11. Pretreatment antimüllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy.
    Dillon KE, Sammel MD, Prewitt M, Ginsberg JP, Walker D, Mersereau JE, Gosiengfiao Y, Gracia CR.
    Fertil Steril; 2013 Feb 01; 99(2):477-83. PubMed ID: 23084267
    [Abstract] [Full Text] [Related]

  • 12. Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure.
    Knauff EA, Eijkemans MJ, Lambalk CB, ten Kate-Booij MJ, Hoek A, Beerendonk CC, Laven JS, Goverde AJ, Broekmans FJ, Themmen AP, de Jong FH, Fauser BC, Dutch Premature Ovarian Failure Consortium.
    J Clin Endocrinol Metab; 2009 Mar 01; 94(3):786-92. PubMed ID: 19066296
    [Abstract] [Full Text] [Related]

  • 13. Antimüllerian hormone as a measure of reproductive function in female childhood cancer survivors.
    Lunsford AJ, Whelan K, McCormick K, McLaren JF.
    Fertil Steril; 2014 Jan 01; 101(1):227-31. PubMed ID: 24083876
    [Abstract] [Full Text] [Related]

  • 14. Antimullerian hormone in cases of different reproductive pathologies.
    Barbakadze L, Kristasashvili J.
    Georgian Med News; 2014 Jan 01; (232-233):16-21. PubMed ID: 25214265
    [Abstract] [Full Text] [Related]

  • 15. Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).
    Giuseppe L, Attilio G, Edoardo DN, Loredana G, Cristina L, Vincenzo L.
    Hematology; 2007 Apr 01; 12(2):141-7. PubMed ID: 17454195
    [Abstract] [Full Text] [Related]

  • 16. Subclinical Hypothyroidism Is Associated with Lower Ovarian Reserve in Women Aged 35 Years or Older.
    Rao M, Wang H, Zhao S, Liu J, Wen Y, Wu Z, Yang Z, Su C, Su Z, Wang K, Tang L.
    Thyroid; 2020 Jan 01; 30(1):95-105. PubMed ID: 31650898
    [Abstract] [Full Text] [Related]

  • 17. Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors.
    Su HI, Sammel MD, Green J, Velders L, Stankiewicz C, Matro J, Freeman EW, Gracia CR, DeMichele A.
    Cancer; 2010 Feb 01; 116(3):592-9. PubMed ID: 19918920
    [Abstract] [Full Text] [Related]

  • 18. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
    Kunt C, Ozaksit G, Keskin Kurt R, Cakir Gungor AN, Kanat-Pektas M, Kilic S, Dede A.
    Arch Gynecol Obstet; 2011 Jun 01; 283(6):1415-21. PubMed ID: 21562964
    [Abstract] [Full Text] [Related]

  • 19. Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age.
    Steiner AZ, Pritchard D, Stanczyk FZ, Kesner JS, Meadows JW, Herring AH, Baird DD.
    JAMA; 2017 Oct 10; 318(14):1367-1376. PubMed ID: 29049585
    [Abstract] [Full Text] [Related]

  • 20. Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: serum AMH, inhibin B and antral follicle count.
    Yilmaz N, Uygur D, Inal H, Gorkem U, Cicek N, Mollamahmutoglu L.
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul 10; 169(2):257-60. PubMed ID: 23664458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.